Rush to complete an ambitious infrastructure plan in India (FNI)

Source: Seeking Alpha

Apr. 3, 2018 6:15 PM ET | By: Omer I., SA News Editor

  • India is rushing to complete its ambitious infrastructure plan before the next elections, and is spending a record $18B this year to build highways and improve roads across the nation.
  • With elections a year away, Prime Minister Narendra Modi and his administration are increasing government spending and had promised 10M new jobs a year to accelerate economic growth.
  • Spending on roads is up 44% Y/Y, with the government planning to construct 52,000 miles of roads under a five-year $106B development plan.
  • “The renewed focus on road building will continue to improve connectivity thereby enhancing the overall efficiency in the economy,” said Shubhada M Rao, chief economist at Yes Bank Ltd. “Focus on road building will also help employment generation.”

First Trust Value Line Dividend Index Fund Dividend Announcement (FVD)

DIVIDEND ANNOUNCEMENT: First Trust Value Line Dividend Index Fund (NYSE:FVD) today declared a dividend of $0.1344 per share

March 21, 2018

First Trust Value Line Dividend Index Fund (NYSE:FVD) today declared a dividend of $ 0.1344 per share payable on March 29, 2018 to shareholders of record as of March 23, 2018. Dividend amount recorded is a decrease of $ 0.0705 from last dividend Paid.

First Trust Value Line Dividend Index Fund (NYSE:FVD) has paid dividends since 2007, has a current dividend yield of 2.12% and has increased its dividends for 2 successive years.

First Trust Value Line Dividend Index Fund’s market cap is $ 4,057,338,840 and has a PE ratio of 0.00. The stock price closed yesterday at $ 30.18 and has a 52 week low/high of $ 28.54 and $ 31.85.

For more information on First Trust Value Line Dividend Index Fund click here.
First Trust Value Line Dividend Index Fund current dividend information as per the date of this press release is:
Dividend Declaration Date: March 21, 2018
Dividend Ex Date: March 22, 2018
Dividend Record Date: March 23, 2018
Dividend Payment Date: March 29, 2018
Dividend Amount: $ 0.1344

Source:  https://www.dividendinvestor.com/dividend-news/20180321/dividend-announcement-first-trust-value-line-dividend-index-fund-nyse-fvd-today-declared-a-dividend-of-$0.1344-per-share/

Best Long-Term Performance International Large Cap Value ETFs 1.1

The International (Foreign) Large Cap Value asset class is a difficult asset class to research. The reason being is that there haven’t been funds available for very long in this asset class. The older mutual funds available in this asset class have only been around since the mid 1990’s. The oldest ETF available in this category is the BLDRS Developed Markets 100 ADR Index Fund (ADRD), inception December 2002. So, without significant fund data to compare this asset class with others, I am relying heavily on the expertise of historians, academic studies and reliable financial experts.

Continue reading “Best Long-Term Performance International Large Cap Value ETFs 1.1”

Best Long-Term Performance China Equity ETFs 1.1

– The oldest available China Equities ETF (FXI) has outperformed an S&P 500 index fund by 1.81% CAGR (compound annual growth rate) over the last 13 years
– There are currently 6 ETFs available that have over 50% exposure to Chinese equities that are 10 years old or older
– 3 of these ETFs have significantly outperformed FXI over the last 10 years
– 1 of these ETFs adds exposure to India without degrading long-term returns
– China encompass approximately 19% of the world’s population

Continue reading “Best Long-Term Performance China Equity ETFs 1.1”

Sold Some Of Our Biotech Equity Holdings Today (FBT)

We sold some of our Biotech holdings today. I don’t currently see any problems in this is industry or this particular ETF at this time. We only sold to use the funds in another endeavor. Price paid $89.36, price sold $117.12. The First Trust NYSE Arca Biotechnology Index Fund (FBT : $FBT) is still a great fund and I still recommend it to other investors. I wrote about FBT back in January 2017 and updated the charts in the article in May 2017 right here: Discovering Value in Growth Stock Funds: Biotech ETFs

Are Biotech Funds Buys Once Again?

Are Biotech Funds Buys Once Again?

While a number of market industries were fearful of a Trump Presidency, nowhere was the concern more prevalent than in the biotech and drug segment. After all, Trump came out several times against the pricing practices in the drug market, vowing to do something to make this a more affordable area…. (Read full article at Zacks.)

Trimmed some more fat off our Biotech Equities today (FBT)

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.